Insiders · Profile

Lippman Evan

EVP, Business Development at TEVA PHARMACEUTICAL INDUSTRIES. Filing since 14 May 2026. CIK 0002062834

Company
Date
Role
Action
Shares
Amount
Of holding
17 Aug 2026
EVP, Business Development
Sold on a plan
18,600
$680.29K
42.1%
14 May 2026
EVP, Business Development
Sold on a plan
41,658
$1.48M
87.2%
2 decisions on file.